No absolute contraindication.

Imdevimab and casirivimab combination is not authorized for use in patients with any of the following:

- Age < 12 years and weight < 40 kg

- Hospitalized due to COVID-19

- Requiring oxygen support

- Requiring increase in baseline oxygen flow due to COVID-19 in patients on chronic oxygen therapy due to underlying non-COVID-19 related comorbidities